Chongqing Medical University Students Visit VCBeat for Immersive Learning on Digital Therapeutics

AsA Leading Medical Service Platform in the Field of Digital Therapeutics, VCBeat has always adhered to the principle and philosophy of providing advanced digital healthcare information.

VCBeat is committed to cognition, leadership, and service, continuously exploring the optimal integration of digital therapeutics with the existing healthcare industry. In terms of stakeholders, it focuses on patients, physicians, and investment institutions; in terms of applications, it conducts in-depth research into the impact of digital therapeutics on neurological, cardiovascular, and oncological conditions.

Students from the specialized class in digital medical laboratory technology further explored and sought knowledge in the field of “digital therapeutics” at VCBeat.

At the special lecture,VCBeat CEO Liu HuiguangProvides a comprehensive and detailed overview of the current state of the digital therapeutics industry, operational strategies, development prospects, and talent cultivation.

He also shared with great interest VCBeat’s years of exploration and innovation in serving the digital therapeutics field, thereby enhancing students’ understanding of this emerging industry.

Subsequently, to help students truly establish an industrialization perspective,Ye Yanyan, Researcher at VBInsightAn In-Depth Analysis of the Development and Prospects of Digital Therapeutics

Ye Yanyan stated that the rapid development of the digital therapeutics industry has far exceeded expectations, currently garnering significant attention across the entire health and wellness sector. Meanwhile, digital therapeutics are treatment or intervention measures driven by high-quality software programs, representing a recognized multidisciplinary field.

In addition to software technology, it also involves a wide range of digital technologies, such as wireless networks, sensors, microprocessors and integrated circuits, artificial intelligence, cloud computing and big data, and VR/AR/MR technologies. The empowerment of these digital technologies has laid the foundation for the realization of digital therapeutics products.

Furthermore, emerging cloud computing and software development technologies are also being introduced during specific periods and within particular processes to empower digital therapeutics.

During the discussion and learning session, Ye Yanyan expressed her hope that students would gain deeper insights into the current status and future development directions of digital therapeutics in China, rather than merely limiting themselves to conceptual discussions.

Subsequently, the students delved into the core of VCBeat’s medical product operations. Through discussions and exchanges with industry professionals, they not only gained a detailed understanding of the operational principles and application areas of digital therapeutics but also developed an appreciation for the translation of scientific research achievements in the healthcare sector.

Questioning and Learning: Complementary Practices.

Following a series of study visits, Liu Huiguang, CEO of VCBeat, and Ye Yanyan, Researcher at VCBeat Institute, provided active Q&A sessions for students on various aspects of the healthcare industry, including the industrialization of digital therapeutics and the operation of professional medical service platforms. This enabled participants to gain a comprehensive and in-depth understanding of both the professional content and commercial applications of digital health.

During the exchange, alumni employed at VCBeat also shared their personal growth experiences in learning and working at the company, helping students gain a deeper understanding of the employment landscape and master job-selection skills.

When asked what the biggest takeaway from VCBeat has been, this employee, who just became a permanent staff member last month, stated: “VCBeat has provided me with a comprehensive perspective, enabling me to clearly see the current state and development trends of the healthcare industry.”

The visit and study tour concluded with enthusiastic questions and discussions on “digital therapeutics” from the students of Chongqing Medical University.

Liu Huiguang, CEO of VCBeat, stated that the event aims to provide outstanding students in medical laboratory science and related disciplines with a “zero-distance” platform for exchange, and also represents an important initiative by the company to strengthen university–enterprise collaboration and deepen the integration of medicine and engineering.

The visit and exchange by students from Chongqing Medical University is just the beginning. Moving forward, VCBeat will engage in comprehensive cooperation with the School of Laboratory Medicine at Chongqing Medical University to jointly build a leading hub for future medical-engineering integration, bringing more possibilities to the healthcare industry.